VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 450.8 USD | +0.73% |
|
+2.31% | +10.79% |
| May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
| May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 322 M€ | +13.88% | - | |
| 0.13% | 29 M€ | -.--% | - | |
| 0.13% | 1 M€ | +3.03% | - | |
| 0.12% | 34 M€ | +9.41% | - | |
| 0.11% | 104 M€ | +9.59% | ||
| 0.11% | 391 M€ | +9.34% | - | |
| 0.09% | 306 M€ | +6.59% | - | |
| 0.09% | 39 M€ | +6.34% | - | |
| 0.08% | 756 M€ | -0.15% | - | |
| 0.08% | 2 M€ | +3.16% | - | |
| 0.06% | 12 M€ | +15.05% | - | |
| 0.05% | 6 M€ | +3.89% | ||
| 0.05% | 105 M€ | +3.84% | - | |
| 0.05% | 17 M€ | +3.49% | - | |
| 0.04% | 112 M€ | +3.77% | - | |
| 0.03% | 54 M€ | +0.73% | - | |
| 0.03% | 8 M€ | +0.94% | - | |
| 0.02% | 234 M€ | +7.37% | - | |
| 0.02% | 6 M€ | -4.26% | - | |
| 0.01% | 169 M€ | -0.28% | - | |
| 7.21% | 129 M€ | +7.70% | - | |
| 8.05% | 28 M€ | +7.52% | - |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
450.8
USD
Average target price
462.8
USD
Spread / Average Target
+2.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.79% | 116B | |
| +11.65% | 106B | |
| -6.20% | 23.89B | |
| -2.33% | 21.58B | |
| -6.03% | 18.96B | |
| -13.41% | 16.33B | |
| -40.50% | 16.96B | |
| +6.64% | 14.14B | |
| +31.84% | 12.02B | |
| -34.35% | 7.2B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated
